PMV Pharmaceuticals, Inc.·4

Jun 8, 7:24 PM ET

Jalota Deepika 4

4 · PMV Pharmaceuticals, Inc. · Filed Jun 8, 2021

Insider Transaction Report

Form 4
Period: 2021-05-12
Jalota Deepika
Chief Development Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-05-12+22,67422,674 total
    Exercise: $28.33Exp: 2031-05-11Common Stock (22,674 underlying)
Footnotes (1)
  • [F1]Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2021.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION